Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Carrie Underwood, Guns N’ Roses Reunite
One day after reports that Carrie Underwood was leaning hard...
Health Care Roundup: Market Talk
Find insight on Lundbeck, HaItian International, Telix Pharmaceuticals and...
JaMarcus Shephard pays tribute to Mike Leach with gameday outfit
Sep 21, 2026, 01:11 PM ETJaMarcus Shephard is paying...
Ex-attorney Matthew Exton gets up to 24 years in prison for trying to shoot ex-wife inside a Toledo restaurant
A former lawyer who stormed into an Ohio restaurant...